Cargando…
Second-degree Heart Block Caused by Itolizumab-induced Infusion Reaction in COVID-19
How to cite this article: Kumar A, Kumar N, Lenin D, Kumar A, Ahmad S. Second-degree Heart Block Caused by Itolizumab-induced Infusion Reaction in COVID-19. Indian J Crit Care Med 2021;25(4):474–475.
Autores principales: | Kumar, Abhyuday, Kumar, Neeraj, Lenin, Dharani, Kumar, Amarjeet, Ahmad, Shaheen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138653/ https://www.ncbi.nlm.nih.gov/pubmed/34045820 http://dx.doi.org/10.5005/jp-journals-10071-23794 |
Ejemplares similares
-
Severe bronchospasm following itolizumab infusion in a COVID-19 patient
por: Kumar, Neeraj, et al.
Publicado: (2022) -
Itolizumab/sodium chloride: Second degree heart block secondary to infusion related hypersensitivity reaction: case report
Publicado: (2021) -
Painful Blisters of Left Hand Following Extravasation of Remdesivir Infusion in COVID-19
por: Kumar, Neeraj, et al.
Publicado: (2021) -
Unusual cause of hypoxia due to incomplete removal of the closed suction catheter system during COVID-19 ventilation
por: Kumar, Neeraj, et al.
Publicado: (2021) -
Acute Exacerbation of Cough as a Precipitating Cause of Hypoxia in COVID-19 Patients
por: Kumar, Amarjeet, et al.
Publicado: (2021)